COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 9, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 8, 2022
New Study Identifies Key Risk Factors Likely to Accelerate a COPD Diagnosis in Patients with Asthma
New research highlights several key risk factors that are likely to accelerate the progression from asthma to COPD, including older age and prior tobacco use.
Severe Uncontrolled Asthma: 5 Questions on Key Characteristics
Optimal use of biologic therapy for severe uncontrolled asthma rests on understanding of the disease itself. Try this quick quiz to test your knowledge.
SGLT-2 Inhibitors and GLP-1 RAs May Reduce NAFLD Risk in T2D
Use of SGLT2 inhibitor and GLP-1 RA therapy in patients with type 2 diabetes appears to confer hepatic protection when compared with use of DPP-4 inhibitors.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 7, 2022
Tezepelumab Reduced Inflammatory Biomarkers of Severe Asthma in as Little as 2 Weeks
New data from the phase 3 NAVIGATOR trial found tezepelumab treatment reduced inflammatory biomarkers of severe, uncontrolled asthma in as little as 2 weeks.
Real Time CGM Improves A1c, Time in Range in T2D Patients on Less Intensive Treatment
Greatest improvements in A1c, %TIR, and other glycemic parameters were seen in patients treated with ≤1 medication, in another challenge to current payer restrictions.
Call for a NAFLD Care Pathway in T2D in Primary Care
Integrating NAFLD as a diabetes complication to be addressed during routine cycles of care could reduce barriers to a NAFLD pathway in primary care, agreed focus group participants.
Your T2D Patient Needs Mealtime Insulin: Counsel on Options, then Move Ahead
NYU endocrinologist Brian Levy, MD, offers perspective on keeping the transition from basal insulin to multiple daily injections as simple as possible for patient and provider.
Study: Prior Oral Corticosteroid Use, Hospitalization Raise Risk for Poor COVID-19 Outcomes in Adults with Asthma
Adults with asthma who had a prior hospitalization or required 2 or more courses of oral corticosteroids were at increased risk of poor COVID-19 outcomes, according to a new study.
COVID-19 Hospitalization 23 Times Higher for Unvaccinated During Omicron Surge
The COVID-19 Omicron variant may cause milder disease than the Delta variant, but its rapid spread in Los Angeles County still singled out unvaccinated Angelinos.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 3, 2022
Topline Phase 3 Data for NASH Candidate Resmetirom Set Promising Stage
Adverse events seen with resmetirom were similar across dose and placebo groups and there were "significant reductions" seen in liver fat, LDL-C, and ApoB.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 2, 2022
Barriers to Intensifying Insulin in T2D Management: An Interview on Clinical Inertia
Type 2 diabetes patients-and their PCPs-may have trouble moving to basal + mealtime insulin from basal insulin alone. Endocrinologist Brian Levy, MD, offers insights.
Tezepelumab Reduces Exacerbations in Patients with Severe Asthma Regardless of Season
New data from the phase 3 NAVIGATOR trial demonstrate superior efficacy of tezepelumab to reduce asthma exacerbations in severe disease year round.
Workplace Pesticide Exposure Tied to Higher Risk of COPD, Suggests New Study
Occupational exposure to pesticides was linked to an increased risk of COPD in a large UK study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 1, 2022
Omicron Subvariant BA.2: What We Know Now
Known as BA.2, the new Omicron subvariant is now circulating at low levels in the US. What can you tell your patients? Here's what we know, now.